US Top Rating Updates on 5/16: GILD, NGMS, CFR, GEHC and More

Analysts Notebook wrote a column · May 16, 2023 07:15

$Gilead Sciences (GILD.US)$ Raised to Outperform From Market Perform by BMO Capital

BMO Capital Upgrades Gilead Sciences to Outperform From Market Perform, Adjusts Price Target to $100 From $90.

$Cullen/Frost Bankers (CFR.US)$ Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley

Cullen/Frost Bankers Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley.

$GE HealthCare Technologies (GEHC.US)$ Initiated at Outperform by Oppenheimer

GE HealthCare Techs Price Target Announced at $97.00/Share by Oppenheimer.

Source: Seeking Alpha, Dow Jones

Disclaimer: The content should not be relied on as advice or recommendation.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

155K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

18KFollowers

46Following

38KVisitors